Boric Acid + Chlorpheniramine Maleate + Sodium Chloride + Tetrahydrozoline is an ophthalmic preparation used to provide relief from itching and watering of eyes caused by allergic conjunctivitis or minor eye irritation. It contains chlorpheniramine maleate (a topical antihistamine that reduces itch and watering), tetrahydrozoline (a vasoconstrictor that reduces redness by narrowing the small blood vessels of the conjunctiva), boric acid (a mild antiseptic and buffering agent), and sodium chloride (which keeps the formulation isotonic and comfortable on the eye).
Allergic conjunctivitis is one of the most common eye conditions and is triggered by allergens such as pollen, dust, pet dander, or mould. When the conjunctiva (the thin membrane covering the white of the eye and lining the inner eyelid) comes into contact with an allergen, mast cells release histamine and other inflammatory mediators, causing itching, redness, watering, and swelling. Non-allergic irritation from smoke, air conditioning, or screen use can produce similar symptoms.
Chlorpheniramine maleate is a first-generation antihistamine. On topical application, chlorpheniramine blocks histamine H1 receptors on conjunctival nerve endings, reducing the itching and watering caused by histamine.
Tetrahydrozoline is a sympathomimetic agent that acts on alpha-adrenergic receptors in the small blood vessels of the conjunctiva. By stimulating these receptors, it constricts the vessels and rapidly reduces redness. It does not treat the underlying allergy or inflammation — its action is symptomatic.
Boric acid is a mild antiseptic with weak antibacterial and antifungal activity. In ophthalmic preparations, its main role is as a buffer to maintain the formulation at a comfortable pH close to that of natural tears, with secondary mild antiseptic action. Sodium chloride keeps the formulation isotonic with tear fluid, preventing the discomfort caused by drops that are too dilute or too concentrated.
To use Boric Acid + Chlorpheniramine Maleate + Sodium Chloride + Tetrahydrozoline, wash your hands. Tilt your head back, look up, and gently pull down the lower eyelid to form a small pocket. Hold the bottle above the eye, close to but not touching the eye or lashes, and instil one or two drops into the pocket. Close your eyes gently for a minute and press lightly on the inner corner of the eye to reduce drainage into the nose. Use only as needed for symptomatic relief, and do not use continuously for more than 3 to 5 days without medical advice. This is because prolonged use of decongestant drops can cause rebound redness.
Chlorpheniramine blocks H1 histamine receptors on conjunctival sensory nerve endings. Histamine, released by mast cells (immune cells) during an allergic reaction, normally binds to these receptors and triggers itching, watering, and vasodilation (widening of blood vessels). By blocking H1 receptors, chlorpheniramine prevents these signals from being generated, reducing the itch–scratch–tear cycle of allergic eye disease.
Tetrahydrozoline acts as an alpha-adrenergic agonist. The small arterioles of the conjunctiva have alpha-1 receptors on their smooth muscle walls; when stimulated, the smooth muscle contracts and the vessels narrow. This reduces the amount of blood passing through the conjunctival vessels and rapidly reduces visible redness.
Boric acid maintains the solution at a slightly acidic pH similar to natural tears, which is the most comfortable pH range for the ocular surface. Sodium chloride keeps the osmotic concentration matched to tear fluid, so the drops do not cause discomfort by drawing water into or out of corneal cells.
Avoid in known hypersensitivity to any component.
Use only if clearly needed and for short durations; topical ocular absorption is minimal but not zero.
Use only if clearly needed; consult your doctor.
Vision may blur briefly after instillation; wait until clear before driving.
No specific interaction with topical ocular use.
Negligible systemic absorption from topical ocular use.
Negligible systemic absorption from topical ocular use.
Children absorb topical agents more readily; use only on medical advice in young children.
Watch for systemic effects of tetrahydrozoline; review with your doctor.
Boric Acid + Chlorpheniramine Maleate + Sodium Chloride + Tetrahydrozoline has no clinically significant food interactions when used topically in the eyes.
Accidental ingestion of Boric Acid + Chlorpheniramine Maleate + Sodium Chloride + Tetrahydrozoline, especially by children, can cause serious systemic effects, which can manifest as drowsiness, slow heart rate, low blood pressure, low body temperature, and, in severe cases, coma. Keep this product safely out of reach of children. Suspected ingestion requires urgent medical attention.
This product is used as needed for symptom relief. If you forget a dose, simply apply it when symptoms occur. Do not use more than directed to make up for a missed dose.
Therapeutic Class
Action Class
Ophthalmic antihistamine-decongestant combination eye drop
Chemical Class
First-generation H1 antihistamine (chlorpheniramine); alpha-adrenergic vasoconstrictor (tetrahydrozoline); inorganic mild antiseptic/buffer (boric acid); inorganic salt (sodium chloride)
Habit Forming
No (though rebound redness can encourage repeated use)
Checkout Editorial Policy